Sophia Abene is the Assistant Editor for Contagion. You can email her at abenes@mjhlifesciences.com.
ViiV Healthcare Presents Potential Long-Acting HIV Therapies
March 17th 2025Phase 1 data on VH184, a third-generation integrase strand transfer inhibitor, and VH499, a novel HIV-1 capsid inhibitor, highlighting their antiviral potency, safety profiles, and potential for long-acting injectable formulations.
Read More
Pandemic Disruptions in HIV Care Impacted on Early ART Initiation and Viral Suppression
March 13th 2025Sarita Shah, MD, MPH, reveals a decline in timely ART initiation from 86.5% in 2019 to 83.9% in 2020, with viral suppression rates dropping from 91.1% to 84.7%, before showing signs of recovery by 2021.
Read More
The M&M Study: Age-Related T Cell Response in People with HIV on ART in MVA.HIVconsvX Vaccine Trial
March 10th 2025Nilu Goonetilleke, LLBHons, BScHons, presents findings from the phase 1 study, showing a 50% reduction in T cell response with age, while 85% of participants demonstrated strong immune responses.
Read More
How Porphyromonas gingivalis Evasion of Immune Detection May Fuel Systemic Diseases
February 28th 2025New study by Gabriel Nussbaum, MD, PhD, et al, reveals how P gingivalis escapes immune detection, contributing to gum disease and increasing risks for systemic infections such as respiratory disease.
Read More